Orthopaedic Oncology Service

Orthopaedic Care During COVID-19

Compassionate, Multidisciplinary Treatment

For more than 45 years, the Mass General Orthopaedic Oncology Service has treated children, adolescents and adults with primary bone and soft tissue tumors (benign and malignant) and metastatic disease.

Bone and soft tissue sarcomas are among the rarest malignant tumors treated. There are approximately 3,000 new cases of primary bone tumors each year, which accounts for less than 0.2% of all adult cancer cases. And there are approximately 13,000 new primary soft tissue tumors each year, which account for 1% of all adult cancer cases. Because of this, we take a comprehensive approach to treating these rare tumors, incorporating every resource the hospital has to offer to ensure our patients receive the best and most current treatment available.

Treatment plans are coordinated through our team approach and includes orthopaedic oncology surgeons, radiation oncologists, medical oncologists, pathologists, radiologists and nurse practitioners. Medical and surgical experts work together seamlessly to provide treatment programs that are individually designed for each patient. We carefully assess outcomes and take pride in making it possible for our patients to live their lives as fully as possible.

Patient Resources

An icon representing patient resources
Conditions & Treatments

Conditions & Treatments

Our comprehensive patient education hub created by our clinicians for our patients.

An icon representing research
Harris Center for Chordoma Care

Harris Center for Chordoma Care

A multidisciplinary center created to support chordoma patients.

An icon representing patient education
ICAN: Amputee Network

ICAN: Amputee Network

A new collaboration with orthopaedic surgeons, plastic surgeons and rehab specialists.

Learn more

Learn more about Orthopaedic Oncology from two of our surgeons, Dr. Kevin Raskin and Dr. Santiago Lozano-Calderon